martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 14, 2026

Stocks Climb on US-Iran Peace Talk Optimism and a Favorable PPI Report

View original at nasdaq.com
Stocks Climb on US-Iran Peace Talk Optimism and a Favorable PPI Report The S&P 500 Index ($SPX) (SPY) today is up +0.39%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.13%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.76%…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Tim Scott is optimistic that the Trump administration will soon drop its investigation into Fed Chair Powell

    60% confidence
  • Nvidia denied a report that it was seeking to acquire Dell Technologies or HP Inc.

    60% confidence
  • President Trump threatened to retaliate in the event of Iranian resistance to the naval blockade

    60% confidence
  • Stripping out the technology sector, Q1 earnings are projected to increase around 3%, the weakest in two years

    60% confidence
  • Scott Kirby floated a possible combination with American Airlines

    60% confidence
  • Q1 S&P 500 earnings projected to climb +12% y/y

    60% confidence
  • Iran would target all ports in and close to the Persian Gulf if its own shipping hubs are threatened

    60% confidence
  • US and Iran are considering negotiations to extend a two-week ceasefire that expires on April 22, and could resume talks this week in Pakistan

    60% confidence
  • Thom Tillis will not vote in favor of Kevin Warsh until the Trump administration drops its threat to prosecute Fed Chair Powell for cost overruns on the Fed building

    60% confidence
  • Faster inflation due to the Iran war doesn't make an interest rate hike self-evident

    60% confidence

Data points we hold from this source

Citigroup Inc. · investment banking revenue1.33 USD

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com